Patients responding to phosphodiesterase type 5 inhibitor therapy - What do their sexual partners know?

Journal of Sexual Medicine

Volumn 4, Issue 1, 2007, Pages 162-165

  Klotz, Theodor ^a   Mathers, Mike ^b   Klotz, Rosemarie ^c   Sommer, Frank ^d  

^a Klinikum Weiden   (Germany)

^b Urological Ambulatory   (Germany)

^c Internal Medicine Ambulatory   (Germany)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Erectile Dysfunction; Male attitudes; PDE5 inhibitors; Sexual partner

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG UTILIZATION; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; HUMAN; HUMAN RELATION; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 33845782022     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2006.00346.x     Document Type: Article

References (13)

1. Aytac IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84: 50-6.
2. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: Results of the "Cologne Male Survey" Int J Impot Res 2000; 12: 305-11.
3. Fisher WA, Rosen RC, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: A females experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med 2005; 2: 675-84.
4. Klotz T, Mathers M, Klotz R, Sommer F. Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra ®)? Int J Impot Res 2005; 17: 2-4.
5. Ackerman M, D'Attilio J, Antoni M, Rhany R, Weinstein D, Politano V. Behavioral approaches to assessing erectile dysfunction. Behav Ther 1995; 6: 31-4.
6. Goldstein I, Fisher WA, Sand M, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P, Bangerter K, Bandel TJ, Derogatis LR. Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: A prospective, randomized, double-blind, placebo-controlled trial. J Sex Med 2005; 2: 819-32.
7. Fisher WA, Meryn S, Sand M, Brandenburg U, Buvat J, Mendive J, Scott S, Tailor A, Torres LO. Communication about erectile dysfunction among men with ED, partners of men with ED, and physicians: The strike up a conversation study (Part I). J Men's Health Gender 2005; 2: 64-78.
8. Fisher WA, Rosen RC, Mollen M, Borck G, Karlin G, Pommerville P, Goldstein I, Bangarter K, Bandel TJ, Derogatis LR, Sand M. Improving the sexual quality of couples affected by erectile dysfunction: A double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med 2005; 2: 699-708.
9. Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using validated questionnaire. Eur Urol 2005; 47: 80-5.
10. Muller MJ, Ruof J, Graf-Morgenstern M, Porst H, Benkert O. Quality of partnership in patients with erectile dysfunction after sildenafil treatment. Pharmacopsychiatry 2001; 34: 91-5.
11. Braun M, Klotz T, Mathers MJ, Klingebiel J, Zumbé J, Schoenenberger A, Engelmann U. "Viagra-effect"influence of mass media on patient behavior. Urol Int 2001; 66: 145-8.
12. Perelman M, Shabsigh R, Seftel A, Althof S, Lockhart D. Attitudes of men with erectile dysfunction: A cross-national survey. J Sex Med 2005; 2: 397-406.
13. DeBoer BJ, Botts ML, Lycklama à Nijeholt AAB, Moors JPC, Verheij ThJM. The prevalence of bother acceptance, and need for help in men with erectile dysfunction. J Sex Med 2005; 2: 445-50.